This is the authors' abstract. We don't add key points for this paper.
Mesenchymal lineage marker PDGFRβ is exclusively activated in tumorigenic LAM and renal AML tumors
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Unachukwu et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: